Products
19012 Results
| Quick actions | ISIN | UL | Product | Direction | SL | Ref. | Bid | Spread | Ask | Ratio | % day | % week | % month | Issue date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis Constant Leverage with ISIN code: CH1276587263 | Novartis | Constant Leverage | Short | ― | 101.48 | 1.9 | 0.030 | 1.93 | 1 | -1.55% | -10.80% | 9.83% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416655 | Novartis | Constant Leverage | Short | ― | 101.48 | 0.65 | 0.030 | 0.68 | 1 | -4.41% | -30.11% | 18.18% | 12 May. 2025 | |
| Novartis Constant Leverage with ISIN code: CH1276587248 | Novartis | Constant Leverage | Short | ― | 101.48 | 0.12 | 0.030 | 0.15 | 1 | -20.00% | -33.33% | 9.09% | 13 Oct. 2023 | |
| Novartis Constant Leverage with ISIN code: CH1423416663 | Novartis | Constant Leverage | Short | ― | 101.48 | 1.21 | 0.030 | 1.24 | 1 | -2.42% | -24.84% | 19.80% | 12 May. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587339 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 0.017 | ― | ― | 1 | 0.00% | -10.53% | -29.17% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968495 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 1.91 | 0.050 | 1.96 | 1 | -2.55% | -44.48% | -86.50% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993042 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993299 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 0.009 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 11 Mar. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450967372 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | -75.00% | 9 Jul. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968487 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 3.9 | 0.070 | 3.97 | 1 | -1.76% | -34.23% | -74.98% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1396327889 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 0.001 | ― | ― | 1 | 0.00% | 0.00% | 0.00% | 29 Jan. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1450968479 | Novo Nordisk | Constant Leverage | Long | ― | 314.116 | 6.67 | 0.080 | 6.75 | 1 | -1.19% | -23.60% | -57.49% | 21 Aug. 2025 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1276587321 | Novo Nordisk | Constant Leverage | Short | ― | 314.116 | 9.07 | 0.110 | 9.18 | 1 | -1.20% | 24.59% | 79.25% | 13 Oct. 2023 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1290993018 | Novo Nordisk | Constant Leverage | Short | ― | 314.116 | 0.88 | 0.030 | 0.91 | 1 | -3.30% | 33.33% | 109.52% | 23 Feb. 2024 | |
| Novo Nordisk Constant Leverage with ISIN code: CH1423415707 | Novo Nordisk | Constant Leverage | Short | ― | 314.116 | 0.56 | 0.030 | 0.59 | 1 | -5.08% | 43.59% | 133.33% | 7 May. 2025 | |
| Nvidia Constant Leverage with ISIN code: CH1119068000 | Nvidia | Constant Leverage | Long | ― | 198.805 | 207.22 | 0.490 | 207.71 | 1 | -0.24% | -15.40% | 16.08% | 12 May. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1199369815 | Nvidia | Constant Leverage | Long | ― | 198.805 | 31.04 | 0.080 | 31.12 | 1 | -0.26% | -19.67% | 15.61% | 27 Jun. 2022 | |
| Nvidia Constant Leverage with ISIN code: CH1246614460 | Nvidia | Constant Leverage | Long | ― | 198.805 | 4.81 | 0.020 | 4.83 | 1 | -0.41% | -24.01% | 13.18% | 3 Feb. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1246615640 | Nvidia | Constant Leverage | Long | ― | 198.805 | 0.87 | 0.010 | 0.88 | 1 | -1.14% | -23.68% | 11.54% | 8 Jun. 2023 | |
| Nvidia Constant Leverage with ISIN code: CH1423415673 | Nvidia | Constant Leverage | Long | ― | 198.805 | 185.58 | 1.220 | 186.8 | 1 | -0.65% | -41.65% | -13.57% | 7 May. 2025 |
The underlying prices shown are not real-time prices, i.e. they are delayed due to legal requirements of the data provider. As a consequence, the price of the product on a specific underlying may substantially differ from the price of the product that you would expect on the basis of the underlying price displayed.